Migraine is a complex genetic disorder. A lot of people think that it is a headache disorder, and traditional classification methods have reinforced this idea. However, recent changes in thinking have added a new perspective on this crippling condition, and added a number of different avenues of management that could help migraine sufferers.
Central to the migraine process are the effects noticed in the brain; migraine sufferers are genetically and neurochemically different to the general population. Migraine sufferers display a reduced ability to inhibit a range of functions in the body. These include pain, light sensitivity, sound sensitivity, anxiety, muscle contraction and a host of others. This inability gives rise to the varied symptom profiles that migraine sufferers often present with.
A number of environmental “triggers” have been identified as common aggravating factors for migraine sufferers. These include alcohol, certain foods, stress, hormonal changes and vitamin deficiencies. The tricky part is that not all of these affect everyone equally, which is what makes this condition inherently difficult to diagnose and treat appropriately. Current evidence states that true migraine can't generally be cured, but like asthma or diabetes needs to be managed over time to give a positive outcome.
At NT Chiropractic Health & Wellness Centre, we recognise the complicated nature of the migraine syndrome and our chiropractor, Dr Greg, has a passion and enthusiasm for assisting with this condition. He will discuss your personal migraine experience with you in detail during your case history and determine the most appropriate course of action. He will consider a range of strategies including specific chiropractic adjustments, nutrition, sleep patterns, stress management, supplements or exercise to find the most effective method of managing your migraine syndrome.
Stronks, D. L., Tulen, J. H. M., Bussmann, J. B. J., Mulder, L. J. M. M., &Passchier, J. (2004). Interictal daily functioning in migraine. Cephalalgia, 24(4), 271–279. doi:10.1111/j.1468-2982.2004.00661.x
Seidel, S., Hartl, T., Weber, M., Matterey, S., Paul, A., Riederer, F., et al. (2009). Quality of sleep, fatigue and daytime sleepiness in migraine - a controlled study. Cephalalgia, 29(6), 662–669. doi:10.1111/j.1468-2982.2008.01784.x
Masruha, M. R., Lin, J., de Souza Vieira, D. S., Minett, T. S. C., Cipolla-Neto, J., Zukerman, E., et al. (2010). Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities. Headache, 50(3), 413–419. doi:10.1111/j.1526-4610.2009.01547.x
Bruera, O., Sances, G., Leston, J., Levin, G., Cristina, S., Medina, C., et al. (2008). Plasma melatonin pattern in chronic and episodic headaches. Evaluation during sleep and waking. Functional neurology, 23(2), 77–81.
Peres, M. F., Masruha, M. R., Zukerman, E., Moreira-Filho, C. A., &Cavalheiro, E. A. (2006). Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opinion on Investigational Drugs, 15(4), 367–375. doi:10.1517/13543722.214.171.1247
Lovati, C., D'Amico, D., Bertora, P., Raimondi, E., Rosa, S., Zardoni, M., et al. (2010). Correlation between presence of allodynia and sleep quality in migraineurs. Neurological sciences, 31 Suppl 1, S155–8. doi:10.1007/s10072-010-0317-2
Tanuri, F. C., Lima, E., Peres, M. F. P., Cabral, F. R., GraçaNaffah-Mazzacoratti, M., Cavalheiro, E. A., et al. (2009). Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin. The journal of headache and pain, 10(2), 105–110. doi:10.1007/s10194-009-0097-3
Peres, M. F. P., Zukerman, E., da Cunha Tanuri, F., Moreira, F. R., &Cipolla-Neto, J. (2004). Melatonin, 3 mg, is effective for migraine prevention. Neurology, 63(4), 757.
Peres M, Gonçalves AL. Double-blind, placebo controlled, randomized clinical trial comparing melatonin 3 mg, amitriptyline 25 mg, and placebo for migraine prevention. Program and abstracts of the American Academy of Neurology 65th Annual Meeting, March 16-23, 2013; San Diego, California. Abstract S40.005.
Lu, WZ, Gwee, KA, Moochhalla, S, Ho, KY (2005). Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Alimentary Pharmacology and Therapeutics, 22(10), 927–934. doi:10.1111/j.1365-2036.2005.02673.x
Romanello, S., Spiri, D., Marcuzzi, E., Zanin, A., Boizeau, P., Riviere, S., et al. (2013). Association between childhood migraine and history of infantile colic. JAMA, 309(15), 1607–1612. doi:10.1001/jama.2013.747
Cohen Engler, A., Hadash, A., Shehadeh, N., & Pillar, G. (2011). Breastfeeding may improve nocturnal sleep and reduce infantile colic: Potential role of breast milk melatonin. European journal of pediatrics, 171(4), 729–732. doi:10.1007/s00431-011-1659-3
Yoon, M.-S., Manack, A., Schramm, S., Fritsche, G., Obermann, M., Diener, H.-C., et al. (2013). Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: Results of the German Headache Consortium study. Pain, 154(3), 484–492. doi:10.1016/j.pain.2012.12.010
Rocca MA, Ceccarelli A, Falini A, Colombo B, Tortorella P, Bernasconi L, Comi G, Scotti G, Filippi M. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke 2006;37:1765–70.
Ishizaki, K., Mori, N., Takeshima, T., Fukuhara, Y., Ijiri, T., Kusumi, M., et al. (2002). Static stabilometry in patients with migraine and tension-type headache during a headache-free period. Psychiatry and Clinical Neurosciences, 56(1), 85–90.
Bendik, E. M., Tinkle, B. T., Al-shuik, E., Levin, L., Martin, A., Thaler, R., et al. (2011). Joint hypermobility syndrome: A common clinical disorder associated with migraine in women. Cephalalgia, 31(5), 603–613. doi:10.1177/0333102410392606Wheeler, S. (2008).
Vitamin D Deficiency in Chronic Migraine. Headache, 48, 1–2.
Gelfand, A. American Academy of Neurology (AAN) 64th Annual Meeting. Abstract 113. April 21 - 28, 2012. First results released February 20, 2012.
Carson, L., Lewis, D., Tsou, M., McGuire, E., Surran, B., Miller, C., & Vu, T.-A. (2011). Abdominal migraine: an under-diagnosed cause of recurrent abdominal pain in children. Headache, 51(5), 707–712. doi:10.1111/j.1526-4610.2011.01855.x
Al-Twaijri, W. A., &Shevell, M. I. (2002). Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatric neurology, 26(5), 365–368.
Wiberg, J. M., Nordsteen, J., & Nilsson, N. (1999). The short-term effect of spinal manipulation in the treatment of infantile colic: a randomized controlled clinical trial with a blinded observer. Journal of manipulative and physiological therapeutics, 22(8), 517–522.
Wiberg, K. R., &Wiberg, J. M. M. (2010). A retrospective study of chiropractic treatment of 276 danish infants with infantile colic. Journal of manipulative and physiological therapeutics, 33(7), 536–541. doi:10.1016/j.jmpt.2010.08.004
Piché, M., Arsenault, M., Poitras, P., Rainville, P., &Bouin, M. (2010). Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome. Pain, 148(1), 49–58. doi:10.1016/j.pain.2009.10.005
Zhou, Q., Fillingim, R. B., Riley, J. L., Malarkey, W. B., & Nicholas Verne, G. (2010). Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain, 148(3), 454–461. doi:10.1016/j.pain.2009.12.005
Heymen, S., Maixner, W., Whitehead, W. E., Klatzkin, R. R., Mechlin, B., & Light, K. C. (2010). Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. The Clinical journal of pain, 26(2), 104–109. doi:10.1097/AJP.0b013e3181bff800